Publication | Closed Access

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

Lymphoid NeoplasiaCell TherapyRandomized Phase 2Health SciencesMedicineStem Cell MobilizationImmunologyHematologyPathologyPbpc MobilizationOncologyRadiation OncologyCancer ResearchStem Cell Factor